Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hyeonji Yoo
Institution:
Ewha Womans University
Observed institution:
Ewha Womans University
OpenAlex ID:
A5114212466
Overcoming Cancer Drug Resistance with Nanoparticle Strategies for Key Protein Inhibition
2024
·
Hyeonji Yoo
, Yeonjin Kim
, et al.
·
Molecules
·
45
PDF
Cathepsin B‐Cleavable Doxorubicin Prodrug Nanoparticles for Eliciting Cancer‐Specific Immunogenic Cell Death and Minimizing Systemic Toxicity
2025
·
Nayeon Shim
, Jinseong Kim
, et al.
·
Advanced Healthcare Materials
·
5
Cancer‐Specific and Pro‐Apoptotic PEGylated Liposomes Containing SMAC‐Mimetic Doxorubicin Prodrug for Safe High‐Dose Delivery in Pancreatic Cancer
2025
·
Yeonjin Kim
, Jinseong Kim
, et al.
·
Advanced Healthcare Materials
·
4
High-dose treatment of cathepsin B-activatable doxorubicin prodrug nanoparticles that induce tumor-specific immunogenic cell death for immunotherapy of melanoma with minimal systemic toxicity.
2026
·
Yoojeong Oh
, Jinseong Kim
, et al.
·
PubMed
PDF
Show more works
View as search
Works count:
4
Citation count:
54
H-index:
3
I10-index:
1
Year
Topic
Type
